Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000476336) titled 'Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Pediatric Crohn's Disease: A Multi-Center Trial' on April 17.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Seattle Children's Hospital
Condition:
inflammatory bowel disease
Crohn's disease
inflammatory bowel disease
Crohn's disease
Inflammatory and Immune System - Autoimmune diseases
Oral and Gastrointestinal - Crohn's disease
Intervention:
Participants will be randomised to one of two die...